We are live on ! Find out more
PHK

Point72 Hong Kong Portfolio holdings

AUM $2.18B
1-Year Est. Return 89.02%
This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+89.02%
3 Year Est. Return
+396.1%
5 Year Est. Return
+490.26%
10 Year Est. Return
+2,256.88%
AUM
$2.88B
AUM Growth
-$192M
Cap. Flow
-$389M
Cap. Flow %
-13.48%
Top 10 Hldgs %
24.09%
Holding
2,616
New
690
Increased
430
Reduced
710
Closed
773

Top Buys

Rank Stock Value
1
XPEV icon
XPeng
XPEV
+$75.5M
2
BEKE icon
KE Holdings
BEKE
+$46.5M
3
NTES icon
NetEase
NTES
+$45.4M
4
EDU icon
New Oriental
EDU
+$39.1M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 9.75%
2 Consumer Discretionary 7.29%
3 Communication Services 3.78%
4 Financials 3.51%
5 Healthcare 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PH icon
1276
Parker-Hannifin
PH
$135B
$66K ﹤0.01%
209
-9,837
-98% -$3.04M
CCCC icon
1277
C4 Therapeutics
CCCC
$412M
$65K ﹤0.01%
2,011
+668
+50% +$26.4K
ECPG icon
1278
Encore Capital Group
ECPG
$2.13B
$65K ﹤0.01%
+1,046
New +$58.9K
MSEX icon
1279
Middlesex Water
MSEX
$1.1B
$65K ﹤0.01%
+539
New +$57.3K
RDN icon
1280
Radian Group
RDN
$4.93B
$64K ﹤0.01%
3,034
-14,467
-83% -$320K
CLVS
1281
DELISTED
Clovis Oncology, Inc.
CLVS
$64K ﹤0.01%
+23,623
New +$87.3K
ALLO icon
1282
Allogene Therapeutics
ALLO
$694M
$63K ﹤0.01%
+4,230
New +$74.6K
AVDX
1283
DELISTED
AvidXchange
AVDX
$63K ﹤0.01%
+4,205
New +$87.8K
GD icon
1284
General Dynamics
GD
$106B
$63K ﹤0.01%
+300
New +$60.6K
HNI icon
1285
HNI Corp
HNI
$3.59B
$63K ﹤0.01%
+1,508
New +$60.4K
MCRB icon
1286
Seres Therapeutics
MCRB
$48.4M
$63K ﹤0.01%
+376
New +$59.7K
CALY
1287
Callaway Golf Company
CALY
$3.14B
$63K ﹤0.01%
+2,313
New +$64.2K
ONB icon
1288
Old National Bancorp
ONB
$10.2B
$63K ﹤0.01%
+3,491
New +$62.1K
RVMD icon
1289
Revolution Medicines
RVMD
$44B
$63K ﹤0.01%
2,485
-1,677
-40% -$47.3K
MNTV
1290
DELISTED
Momentive Global Inc. Common Stock
MNTV
$63K ﹤0.01%
+2,985
New +$65.7K
EYE icon
1291
National Vision
EYE
$1.81B
$62K ﹤0.01%
+1,284
New +$68.8K
EGRX
1292
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$62K ﹤0.01%
+1,208
New +$62.6K
KALU icon
1293
Kaiser Aluminum
KALU
$3.02B
$61K ﹤0.01%
648
+181
+39% +$18.3K
LAMR icon
1294
Lamar Advertising Co
LAMR
$16.3B
$61K ﹤0.01%
+505
New +$58.8K
PHR icon
1295
Phreesia
PHR
$773M
$61K ﹤0.01%
1,468
-6,804
-82% -$404K
SIG icon
1296
Signet Jewelers
SIG
$3.76B
$61K ﹤0.01%
699
-347
-33% -$31.9K
AMRS
1297
DELISTED
Amyris Inc.
AMRS
$61K ﹤0.01%
+11,307
New +$106K
BANR icon
1298
Banner Corp
BANR
$2.4B
$60K ﹤0.01%
989
-646
-40% -$38.2K
FLS icon
1299
Flowserve
FLS
$10.2B
$60K ﹤0.01%
1,971
-6,016
-75% -$199K
ACH
1300
Accendra Health
ACH
$214M
$60K ﹤0.01%
+1,382
New +$54.2K

Similar funds

Point72 Hong Kong's Q4 2021 Portfolio in Review

As of Q4 2021, Point72 Hong Kong held 2,616 positions worth $2.88B, down 6.2% from $3.08B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Point72 Hong Kong withdrew a net $389M in Q4 2021, closing 773 positions and reducing 710 holdings. Its most notable exit was TAL Education Group, an estimated $37M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Point72 Hong Kong opened a new position in Riot Platforms worth $20.5M.

  • Point72 Hong Kong's largest Q4 2021 buy was Riot Platforms: 920,169 shares worth $20.5M.
  • Point72 Hong Kong added most to XPeng in Q4 2021, an estimated $75.5M increase.
  • Point72 Hong Kong's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $25.5M.
  • Point72 Hong Kong fully exited TAL Education Group in Q4 2021, selling an estimated $37M.
  • Point72 Hong Kong's ten largest holdings make up 24% of its $2.88B portfolio in Q4 2021.
  • Point72 Hong Kong opened 690 new positions and closed 773 in Q4 2021.
  • Point72 Hong Kong's portfolio value fell 6.2% quarter-over-quarter to $2.88B.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.